HVTN 302

Phase I, HIV vaccine clinical trial

This study is assessing the safety and immune response of 3 experimental mRNA HIV vaccines in healthy, HIV negative adults between the ages of 18 to 55. This study is currently enrolling participants.

Name*
First Last
Email*
Phone*
Consent
I would like to receive information on other Center for Virology and Vaccine Research studies.
Which study are you interested in?*
How did you hear about this study?*
If you learned about our study through other means, please specify here.
Preferred method of contact*
- Phone
- Email
- Either
CAPTCHA

HVTN 302

Center for Virology and Vaccine Research

CVVR Clinical Trials Unit

Affiliates